Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2510275529;75530;75531 chr2:178570828;178570827;178570826chr2:179435555;179435554;179435553
N2AB2346170606;70607;70608 chr2:178570828;178570827;178570826chr2:179435555;179435554;179435553
N2A2253467825;67826;67827 chr2:178570828;178570827;178570826chr2:179435555;179435554;179435553
N2B1603748334;48335;48336 chr2:178570828;178570827;178570826chr2:179435555;179435554;179435553
Novex-11616248709;48710;48711 chr2:178570828;178570827;178570826chr2:179435555;179435554;179435553
Novex-21622948910;48911;48912 chr2:178570828;178570827;178570826chr2:179435555;179435554;179435553
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCT
  • RefSeq wild type template codon: CGA
  • Domain: Fn3-70
  • Domain position: 97
  • Structural Position: 130
  • Q(SASA): 0.0769
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/T None None 0.244 N 0.65 0.267 0.241664281697 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.5463 ambiguous 0.5383 ambiguous -1.933 Destabilizing 0.958 D 0.766 deleterious None None None None N
A/D 0.9949 likely_pathogenic 0.9922 pathogenic -3.178 Highly Destabilizing 0.821 D 0.809 deleterious N 0.50296376 None None N
A/E 0.9852 likely_pathogenic 0.9774 pathogenic -3.005 Highly Destabilizing 0.858 D 0.739 deleterious None None None None N
A/F 0.9469 likely_pathogenic 0.9259 pathogenic -0.757 Destabilizing 0.749 D 0.803 deleterious None None None None N
A/G 0.5745 likely_pathogenic 0.5142 ambiguous -1.735 Destabilizing 0.566 D 0.553 neutral N 0.502710271 None None N
A/H 0.9917 likely_pathogenic 0.9889 pathogenic -1.822 Destabilizing 0.986 D 0.805 deleterious None None None None N
A/I 0.5064 ambiguous 0.4503 ambiguous -0.311 Destabilizing 0.128 N 0.735 deleterious None None None None N
A/K 0.9942 likely_pathogenic 0.991 pathogenic -1.445 Destabilizing 0.858 D 0.759 deleterious None None None None N
A/L 0.5624 ambiguous 0.4954 ambiguous -0.311 Destabilizing 0.299 N 0.635 neutral None None None None N
A/M 0.6566 likely_pathogenic 0.5911 pathogenic -0.875 Destabilizing 0.919 D 0.832 deleterious None None None None N
A/N 0.9622 likely_pathogenic 0.9481 pathogenic -1.9 Destabilizing 0.949 D 0.804 deleterious None None None None N
A/P 0.7916 likely_pathogenic 0.7205 pathogenic -0.621 Destabilizing 0.933 D 0.803 deleterious N 0.473081445 None None N
A/Q 0.9687 likely_pathogenic 0.9595 pathogenic -1.758 Destabilizing 0.949 D 0.812 deleterious None None None None N
A/R 0.9819 likely_pathogenic 0.9767 pathogenic -1.424 Destabilizing 0.858 D 0.806 deleterious None None None None N
A/S 0.3114 likely_benign 0.2755 benign -2.17 Highly Destabilizing 0.392 N 0.61 neutral N 0.490846986 None None N
A/T 0.2956 likely_benign 0.2418 benign -1.895 Destabilizing 0.244 N 0.65 prob.neutral N 0.47002048 None None N
A/V 0.203 likely_benign 0.1742 benign -0.621 Destabilizing 0.005 N 0.331 neutral N 0.469540344 None None N
A/W 0.9969 likely_pathogenic 0.9951 pathogenic -1.433 Destabilizing 0.986 D 0.801 deleterious None None None None N
A/Y 0.9871 likely_pathogenic 0.9817 pathogenic -1.016 Destabilizing 0.858 D 0.798 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.